Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$684M |
| 2 |
Amgen
AMGN
|
+$653M |
| 3 |
Salesforce
CRM
|
+$488M |
| 4 |
Eli Lilly
LLY
|
+$452M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$437M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$815M |
| 2 |
NVIDIA
NVDA
|
+$685M |
| 3 |
TJX Companies
TJX
|
+$488M |
| 4 |
Starbucks
SBUX
|
+$373M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
+$361M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.92% |
| 2 | Healthcare | 18.9% |
| 3 | Consumer Discretionary | 9.38% |
| 4 | Financials | 9.11% |
| 5 | Industrials | 8.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMK
601
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $16.6M | 0.01% |
479,708
-246,741
| -34% | -$8.5M |
|
602
U-Haul Holding Co Series N
UHAL.B
$12.7B
| $16.5M | 0.01% |
275,733
+1,240
| +0.5% | +$78K |
|
603
Medpace
MEDP
$16.3B
| $16.5M | 0.01% |
40,095
-1,029
| -3% | -$407K |
|
604
Wolfspeed
WOLF
$1.12B
| $16.4M | 0.01% |
720,332
-629
| -0.1% | -$16.3K |
|
|
SRCL
605
DELISTED
Stericycle Inc
SRCL
| $16.3M | 0.01% |
280,095
+237,747
| +561% | +$12.2M |
|
606
State Street SPDR S&P Biotech ETF
XBI
$10.1B
| $16.3M | 0.01% |
175,293
-53,568
| -23% | -$4.8M |
|
607
Boeing
BA
$176B
| $16.2M | 0.01% |
89,059
-3,987
| -4% | -$711K |
|
|
HLVX
608
DELISTED
HilleVax
HLVX
| $16.1M | 0.01% |
+1,115,644
| New | +$15.3M |
|
609
Spyre Therapeutics
SYRE
$8.54B
| $15.9M | 0.01% |
673,867
+659,890
| +4,721% | +$22.3M |
|
610
Citigroup
C
$222B
| $15.9M | 0.01% |
250,609
-10,228
| -4% | -$631K |
|
611
Alamos Gold
AGI
$12.1B
| $15.9M | 0.01% |
1,013,865
-1,206
| -0.1% | -$18.9K |
|
612
Praxis Precision Medicines
PRAX
$8.21B
| $15.9M | 0.01% |
381,685
+71,626
| +23% | +$3.38M |
|
613
Adient
ADNT
$1.68B
| $15.9M | 0.01% |
641,727
-55,576
| -8% | -$1.58M |
|
614
Westlake Corp
WLK
$9.35B
| $15.8M | 0.01% |
109,432
+228
| +0.2% | +$35K |
|
|
VRNA
615
DELISTED
Verona Pharma
VRNA
| $15.8M | 0.01% |
1,092,042
-939,952
| -46% | -$13.7M |
|
|
ABVX
616
Abivax
ABVX
$10.9B
| $15.7M | 0.01% |
1,175,514
+323,675
| +38% | +$4.63M |
|
617
Healthcare Services Group
HCSG
$1.57B
| $15.7M | 0.01% |
1,483,876
+564,807
| +61% | +$6.27M |
|
|
SLN
618
Silence Therapeutics
SLN
$511M
| $15.6M | 0.01% |
818,978
+193,114
| +31% | +$4.11M |
|
|
NWLI
619
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $15.4M | 0.01% |
31,032
+7,551
| +32% | +$3.7M |
|
620
Royal Bank of Canada
RY
$294B
| $15.1M | 0.01% |
141,680
+1,384
| +1% | +$142K |
|
|
BELFB
621
Bel Fuse Inc Class B
BELFB
$3.6B
| $15M | 0.01% |
230,565
+224,712
| +3,839% | +$14.1M |
|
622
California Resources
CRC
$4.39B
| $14.8M | 0.01% |
278,722
-8,746
| -3% | -$446K |
|
623
Pfizer
PFE
$143B
| $14.8M | 0.01% |
527,829
-48,346
| -8% | -$1.33M |
|
|
CUK
624
DELISTED
Carnival PLC
CUK
| $14.7M | 0.01% |
854,569
+69,576
| +9% | +$974K |
|
625
Asure Software
ASUR
$235M
| $14.6M | 0.01% |
1,743,977
+6,579
| +0.4% | +$49.7K |
|
Similar funds
Janus Henderson Group's Q2 2024 Portfolio in Review
As of Q2 2024, Janus Henderson Group held 2,619 positions worth $187B, up 1.9% from $183B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Janus Henderson Group's Q2 2024 filing shows 91 new, 630 increased, 1,758 reduced and 101 closed positions. Its largest new stake was UL Solutions: 2,328,210 shares worth $98.2M. The largest sale was Adobe, an estimated $815M.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q2 2024 buy was UL Solutions: 2,328,210 shares worth $98.2M.
- Janus Henderson Group added most to Broadcom in Q2 2024, an estimated $684M increase.
- Janus Henderson Group's biggest Q2 2024 reduction was Adobe, cutting an estimated $815M.
- Janus Henderson Group fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $157M.
- Janus Henderson Group's ten largest holdings make up 32% of its $187B portfolio in Q2 2024.
- Janus Henderson Group opened 91 new positions and closed 101 in Q2 2024.
- Janus Henderson Group's portfolio value rose 1.9% quarter-over-quarter to $187B.
Based on Janus Henderson Group's 13F filing for Q2 2024, filed 14 Aug 2024.